Literature DB >> 9721816

Lamivudine inhibits hepatitis B virus replication in kidney graft recipients.

E Goffin, Y Horsmans, C Cornu, J P Squifflet, Y Pirson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9721816     DOI： 10.1097/00007890-199808150-00025

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  4 in total

1.  Hepatitis B.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  1999-12

Review 2.  Chronic viral hepatitis in kidney transplantation.

Authors:  Janna Huskey; Alexander C Wiseman
Journal:  Nat Rev Nephrol       Date:  2011-02-01       Impact factor: 28.314

Review 3.  Lamivudine. A review of its therapeutic potential in chronic hepatitis B.

Authors:  B Jarvis; D Faulds
Journal:  Drugs       Date:  1999-07       Impact factor: 9.546

4.  Efficacy and tolerability of lamivudine in hepatitis B infected renal transplant recipients: A single center study.

Authors:  S K Agarwal; S C Tiwari
Journal:  Indian J Nephrol       Date:  2009-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.